ARCHIVES

Long-term Follow-up Shows ADH and ALH Tissue Abnormalities Can Carry Similar Risk

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

DCBDC Advisors Okay New Program In Breast Cancer

July 3, 1992

Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years

May 9, 2014

NCI Division Directors Seek Litton Phaseout, NIH Takeover At Frederick

October 27, 1978

Ken Endicottm, Who Led NCI During “Golden Years,” Dies; Helped Establish Chemotherapy, Virology

July 24, 1987

Nucynta ER Approved For Managing Chronic Pain In Adults

September 30, 2011

In Brief: George Burton Retires After 23 Years At NCI; MDA Names Bodey Head Of Medical Specialists

February 20, 1987